Form 4: InspireMD Director Thomas J. Kester Reports Stock and Option Grant

Director Thomas J. Kester reports acquisition of restricted stock and options in InspireMD, Inc.

Summary

• Thomas J. Kester, a director of InspireMD, Inc., reported the acquisition of 32,491 shares of common stock and options to purchase 14,836 shares of common stock on January 7, 2025.
• The shares were acquired as a grant and the options have an exercise price of $2.71.
• The restricted stock vests on January 7, 2026, subject to continued service.
• The options also vest and become exercisable on January 7, 2026, subject to continued service.
• Following the transaction, Kester beneficially owns 359,143 shares of common stock and options to purchase 84,947 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports routine insider transactions. The grants are a positive sign of alignment, but not significantly impactful.

Positives

• The grant of restricted stock and options to a director aligns their interests with those of the shareholders.
• The vesting requirements incentivize continued service and commitment to the company.

Industry Context

This filing is a routine disclosure related to insider transactions and is typical for publicly traded companies. It provides transparency regarding the holdings of company insiders.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider ownership.
• The vesting requirements may incentivize the director to work towards the company's success, benefiting shareholders.

Key Dates